References

CBTRUS statistical report: primary brain and other Central nervous system tumors diagnosed in the United States in 2016-2020

10.1093/neuonc/noad149 · 2023 · External reference

EANO guidelines for the diagnosis and treatment of meningiomas

10.1016/s1470-2045(16)30321-7 · 2016 · External reference

Cimpact-NOW update 8: clarifications on molecular risk parameters and recommendations for WHO grading of meningiomas

10.1093/neuonc/noae170 · 2025 · External reference

The 2021 WHO classification of tumors of the central nervous system: a summary

10.1093/neuonc/noab106 · 2021 · External reference

The histopathological spectrum of human meningiomas

2012 · External reference

Mitotic index is an independent predictor of recurrence-free survival in meningioma

10.1111/bpa.12174 · 2015 · External reference

Prognostic significance of the mitotic index using the mitosis marker anti-phosphohistone H3 in meningiomas

10.1309/hxunag34b3cefdu8 · 2007 · External reference

Histopathological prognostic factors of recurrence following definitive therapy for atypical and malignant meningiomas

10.3171/2016.11.jns16913 · 2018 · External reference

Benign meningiomas (WHO grade I) with atypical histological features: correlation of histopathological features with clinical outcomes

10.3171/2015.1.jns142228 · 2016 · External reference

Evaluating risk of recurrence in patients with meningioma

10.3171/2022.6.jns221162 · 2023 · External reference

Surgical outcomes after reoperation for recurrent non-skull base meningiomas

10.3171/2018.6.jns18118 · 2018 · External reference

Unresolved reference

2021 · External reference

Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities

10.1038/s41588-022-01061-8 · 2022 · External reference

Correlations between genomic subgroup and clinical features in a cohort of more than 3000 meningiomas

10.3171/2019.8.jns191266 · 2019 · External reference

Meningioma transcriptomic landscape demonstrates novel subtypes with regional associated biology and patient outcome

10.1016/j.xgen.2024.100566 · 2024 · External reference

Multiplatform genomic profiling and magnetic resonance imaging identify mechanisms underlying intratumor heterogeneity in meningioma

10.1038/s41467-020-18582-7 · 2020 · External reference

A molecularly integrated grade for meningioma

10.1093/neuonc/noab213 · 2022 · External reference

DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis

10.1016/s1470-2045(17)30155-9 · 2017 · External reference

Molecular classification to refine surgical and radiotherapeutic decision-making in meningioma

10.1038/s41591-024-03167-4 · 2024 · External reference

A clinically applicable integrative molecular classification of meningiomas

10.1038/s41586-021-03850-3 · 2021 · External reference

Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses

10.1038/s41591-023-02586-z · 2023 · External reference

Development, validation, and utility of a clinically applicable methylation classifier for recurrence risk prediction in meningiomas

10.1186/s40478-025-02184-9 · 2025 · External reference

The combination of mitotic and Ki-67 indices as a useful method for predicting short-term recurrence of meningiomas

10.1016/s0090-3019(03)00575-5 · 2004 · External reference

Unresolved reference

2024 · External reference

Time-dependent ROC curves for censored survival data and a diagnostic marker

10.1111/j.0006-341x.2000.00337.x · 2000 · External reference

Unresolved reference

2020 · External reference

Unresolved reference

2025 · External reference

Factors affecting peritumoral brain edema in meningioma: special histological subtypes with prominently extensive edema

10.1007/s11060-012-0989-y · 2013 · External reference

Correlation between magnetic resonance imaging grading and pathological grading in meningioma

10.3171/2014.7.jns132359 · 2014 · External reference

Relationship between tumor location, size, and WHO grade in meningioma

10.3171/2018.1.focus17752 · 2018 · External reference

Meningioma grading: an analysis of histologic parameters

10.1097/00000478-199712000-00008 · 1997 · External reference

Integrated Molecular-Morphologic meningioma classification: a multicenter retrospective analysis, retrospectively and prospectively validated

10.1200/jco.21.00784 · 2021 · External reference

Meningioma: International Consortium on Meningiomas consensus review on scientific advances and treatment paradigms for clinicians, researchers, and patients

10.1093/neuonc/noae082 · 2024 · External reference

Optimizing the use of Ki-67 proliferative index as a prognostic biomarker in meningiomas using digital analysis

10.3171/2024.4.jns232857 · 2024 · External reference

The mitosis-specific antibody anti-phosphohistone-H3 (PHH3) facilitates rapid reliable grading of meningiomas according to WHO 2000 criteria

10.1097/01.pas.0000141389.06925.d5 · 2004 · External reference

Phosphohistone-H3 proliferation index is superior to mitotic index and MIB-1 expression as a predictor of recurrence in human meningiomas

10.1093/ajcp/aqw141 · 2016 · External reference

Multiomic and clinical analysis of multiply recurrent meningiomas reveals risk factors, underlying biology, and insights into evolution

10.1126/sciadv.adn4419 · 2024 · External reference

Validation and next-generation update of a DNA methylation-based recurrence predictor for meningioma: a multicenter prospective study

10.1093/neuonc/noae236 · 2025 · External reference

Integrated genomic analyses of de novo pathways underlying atypical meningiomas

10.1038/ncomms16215 · 2018 · External reference

TERT promoter mutations and risk of recurrence in meningioma

10.1093/jnci/djv377 · 2016 · External reference

DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management

10.1093/neuonc/noz061 · 2019 · External reference

Prognostic impact of genetic alterations and methylation classes in meningioma

10.1111/bpa.12970 · 2022 · External reference